Laurus Labs receives approval for anti-malaria tablets
Laurus Labs receives approval for anti-malaria tablets

Laurus Labs receives approval for anti-malaria tablets

Gayathri Udyawar Article rating: 5.0

Leading pharma company Laurus Lab received two USFDA approvals, the company informed post market hours on Monday. The products will be manufactured at the company's plant in Visakhapatnam. 

Index trend and stocks in action March 12, 2019
Index trend and stocks in action March 12, 2019

Index trend and stocks in action March 12, 2019

Karan Dsij Article rating: 5.0

Going ahead, we expect a follow-up move to happen. However, on the upside, the level of 11,260 is likely to act a resistance, while on the downside, the level of 11,120 is likely to act as an immediate support. Stocks in news: KEI Industries, Godfrey Philips India, Piramal Enterprises, Kalpataru Power Transmission, Jet Airways, Laurus Labs and PSP Projects.

Markets may open with a gap-up following positive global cues
Markets may open with a gap-up following positive global cues

Markets may open with a gap-up following positive global cues

Karan Dsij Article rating: 5.0

The outlook for the day is a gap-up start as cues from the across the global are encouraging. However, a very important dilemma in the minds of the the investors would be whether ‘to board a running train or alight from it'. For the current momentum to sustain, a close above 11,260 level is crucial for the Nifty. At the time of writing, the SGX Nifty indicates that Nifty may open with a gain of about half a per cent at 11,264.

Orient Cement, Infibeam surge up 11 per cent
Orient Cement, Infibeam surge up 11 per cent

Orient Cement, Infibeam surge up 11 per cent

Gayathri Udyawar Article rating: 5.0

Stocks of Orient Cement, Infibeam Avenue and Jubilant were up more than 10 per cent on Monday and ranked among the top gainer on BSE exchange. These stocks enjoyed the northwards movement of benchmark indices which were up more than a per cent through the trading sessions.

Jet Airways gets a breather with credit from PNB
Jet Airways gets a breather with credit from PNB

Jet Airways gets a breather with credit from PNB

Nidhi Jani Article rating: 5.0

Jet Airways, which is presently going through turbulent times due to heavy debt and cash crunch, has received temporary breather as it has secured loan worth Rs 2050 crore from the government-owned Punjab National bank in foreign currency term loans (Rs 1100 crore) and a non-fund based credit facility (Rs 950 crore).

Capacite Infra secures orders worth Rs. 486 crore
Capacite Infra secures orders worth Rs. 486 crore

Capacite Infra secures orders worth Rs. 486 crore

Nidhi Jani Article rating: 5.0

Capacit'e Infraprojects informed the bourses that it has received an order from Municipal Corporation of Greater Mumbai to redevelop Harilal Bhagwati Municipal General Hospital at Borivali. The said order amounts to Rs. 486.81 crore. Capacite’s order book (excluding MHADA) as on December 31, 2018, stood at Rs. 7,519 crore.

Should you consider having cyber insurance?
Should you consider having cyber insurance?

Should you consider having cyber insurance?

Henil Shah Article rating: 5.0

You may have come across many insurances that are available in the market. Cyber insurance is the latest addition to the product lines of major insurance companies. Let’s find out whether one should consider cyber insurance policy?

IPO Update: MSTC Limited fixes price band for IPO
IPO Update: MSTC Limited fixes price band for IPO

IPO Update: MSTC Limited fixes price band for IPO

Gayathri Udyawar Article rating: 3.6

Government's e-auctions and procurement solutions company MSTC Limited has fixed the price band for its initial public offering (IPO) at Rs. 121 to 128 per equity share. 

Unichem Labs gains post USFDA inspection
Unichem Labs gains post USFDA inspection

Unichem Labs gains post USFDA inspection

Shohini Nath Article rating: 5.0

The USFDA has completed the inspection at Unichem Laboratories' Ghaziabad facility. The shares gained over 2 per cent intraday, on Monday.


RSS
First26562657265826592661266326642665Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR